According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy.

Australian Health Journal met with 3 speakers at the recent ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.

Dr Amit Saha is a Paediatric Gastroenterologist and Hepatologist and trained paediatric endoscopist based in Perth. He underwent his higher specialist training in Paediatrics within the NHS in the UK, and sub-specialised in Paediatric Gastroenterology Hepatology & Nutrition at busy and prestigious centres in London including The Kings College Hospital.

Adjunct Professor Alanna Geary FACN,
Chief Nursing & Midwifery Officer,
Metro North Hospital Hospital & Health Service, Queensland
talks Nursing Leadership